334 related articles for article (PubMed ID: 32816217)
21. Estimate of Increase in Colorectal Cancer Diagnoses with Expansion of Fecal Immunochemical Testing in an Urban Safety-Net Population.
Connolly JJ; Ahmed HS; Chung EC; Cabral HJ; Nagar A; Tami A; Schroy PC; Mohanty A
Dig Dis Sci; 2024 Feb; 69(2):360-369. PubMed ID: 38041763
[TBL] [Abstract][Full Text] [Related]
22. Fresh vs Frozen Samples and Ambient Temperature Have Little Effect on Detection of Colorectal Cancer or Adenomas by a Fecal Immunochemical Test in a Colorectal Cancer Screening Cohort in Germany.
Chen H; Werner S; Brenner H
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1547-1556.e5. PubMed ID: 27793749
[TBL] [Abstract][Full Text] [Related]
23. Stool DNA Testing for Screening Detection of Colorectal Neoplasia in Alaska Native People.
Redwood DG; Asay ED; Blake ID; Sacco PE; Christensen CM; Sacco FD; Tiesinga JJ; Devens ME; Alberts SR; Mahoney DW; Yab TC; Foote PH; Smyrk TC; Provost EM; Ahlquist DA
Mayo Clin Proc; 2016 Jan; 91(1):61-70. PubMed ID: 26520415
[TBL] [Abstract][Full Text] [Related]
24. The Need for an Integrated Patient Navigation Pathway to Improve Access to Colonoscopy After Positive Fecal Immunochemical Testing: A Safety-Net Hospital Experience.
Thamarasseril S; Bhuket T; Chan C; Liu B; Wong RJ
J Community Health; 2017 Jun; 42(3):551-557. PubMed ID: 27796633
[TBL] [Abstract][Full Text] [Related]
25. Implementation intentions and colorectal screening: a randomized trial in safety-net clinics.
Greiner KA; Daley CM; Epp A; James A; Yeh HW; Geana M; Born W; Engelman KK; Shellhorn J; Hester CM; LeMaster J; Buckles DC; Ellerbeck EF
Am J Prev Med; 2014 Dec; 47(6):703-14. PubMed ID: 25455115
[TBL] [Abstract][Full Text] [Related]
26. Yield of Colonoscopy After a Positive Result From a Fecal Immunochemical Test OC-Light.
Alsayid M; Singh MH; Issaka R; Laleau V; Day L; Lee J; Allison J; Somsouk M
Clin Gastroenterol Hepatol; 2018 Oct; 16(10):1593-1597.e1. PubMed ID: 29660528
[TBL] [Abstract][Full Text] [Related]
27. A combination of clinical risk stratification and fecal immunochemical test results to prioritize colonoscopy screening in asymptomatic participants.
Aniwan S; Rerknimitr R; Kongkam P; Wisedopas N; Ponuthai Y; Chaithongrat S; Kullavanijaya P
Gastrointest Endosc; 2015 Mar; 81(3):719-27. PubMed ID: 25708760
[TBL] [Abstract][Full Text] [Related]
28. [Diagnostic performance of quantitative fecal immunochemical test in detection of advanced colorectal neoplasia].
Lu M; Chen HD; Liu CC; Zhang YH; Wei LP; Lyu ZY; Ren JS; Shi JF; Zou SM; Li N; Dai M
Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Dec; 41(12):2104-2111. PubMed ID: 33378824
[No Abstract] [Full Text] [Related]
29. Implementation of an organized colorectal cancer screening program through quantitative fecal immunochemical test followed by colonoscopy in an urban low-income community: Guidance and strategies.
Ribeiro U; Safatle-Ribeiro AV; Sorbello M; Kishi PHR; Cohend DD; Mattar R; Castilho VLP; Goncalves EMDN; Kawaguti F; Marques CFS; Alves VAF; Nahas SC; Eluf-Neto J
Clinics (Sao Paulo); 2023; 78():100278. PubMed ID: 37639912
[TBL] [Abstract][Full Text] [Related]
30. Quality of colonoscopy in an organised colorectal cancer screening programme with immunochemical faecal occult blood test: the EQuIPE study (Evaluating Quality Indicators of the Performance of Endoscopy).
Zorzi M; Senore C; Da Re F; Barca A; Bonelli LA; Cannizzaro R; Fasoli R; Di Furia L; Di Giulio E; Mantellini P; Naldoni C; Sassatelli R; Rex D; Hassan C; Zappa M;
Gut; 2015 Sep; 64(9):1389-96. PubMed ID: 25227521
[TBL] [Abstract][Full Text] [Related]
31. Time to fecal immunochemical test completion for colorectal cancer screening.
Haas CB; Phipps AI; Hajat A; Chubak J; Wernli KJ
Am J Manag Care; 2019 Apr; 25(4):174-180. PubMed ID: 30986014
[TBL] [Abstract][Full Text] [Related]
32. Older age, symptoms, or anemia: Which factors increase colorectal cancer risk with a positive fecal immunochemical test?
Hamarneh Z; Symonds EL; Kholmurodova F; Cock C
J Gastroenterol Hepatol; 2020 Jun; 35(6):1002-1008. PubMed ID: 31606908
[TBL] [Abstract][Full Text] [Related]
33. Comparative effectiveness of mailed reminders with and without fecal immunochemical tests for Medicaid beneficiaries at a large county health department: A randomized controlled trial.
Brenner AT; Rhode J; Yang JY; Baker D; Drechsel R; Plescia M; Reuland DS; Wroth T; Wheeler SB
Cancer; 2018 Aug; 124(16):3346-3354. PubMed ID: 30004577
[TBL] [Abstract][Full Text] [Related]
34. Costs of colorectal cancer screening with colonoscopy, including post-endoscopy events, among adults with Medicaid insurance.
Fisher DA; Princic N; Miller-Wilson LA; Wilson K; Limburg P
Curr Med Res Opin; 2022 May; 38(5):793-801. PubMed ID: 35243953
[TBL] [Abstract][Full Text] [Related]
35. Long-term performance of colorectal cancerscreening programmes based on the faecal immunochemical test.
Zorzi M; Hassan C; Capodaglio G; Fedato C; Montaguti A; Turrin A; Rosano A; Monetti D; Stocco C; Baracco S; Russo F; Repici A; Rugge M
Gut; 2018 Dec; 67(12):2124-2130. PubMed ID: 29101260
[TBL] [Abstract][Full Text] [Related]
36. Participation in Competing Strategies for Colorectal Cancer Screening: A Randomized Health Services Study (PICCOLINO Study).
Pilonis ND; Bugajski M; Wieszczy P; Rupinski M; Pisera M; Pawlak E; Regula J; Kaminski MF
Gastroenterology; 2021 Mar; 160(4):1097-1105. PubMed ID: 33307024
[TBL] [Abstract][Full Text] [Related]
37. New fecal bacterial signature for colorectal cancer screening reduces the fecal immunochemical test false-positive rate in a screening population.
Malagón M; Ramió-Pujol S; Serrano M; Amoedo J; Oliver L; Bahí A; Miquel-Cusachs JO; Ramirez M; Queralt-Moles X; Gilabert P; Saló J; Guardiola J; Piñol V; Serra-Pagès M; Castells A; Aldeguer X; Garcia-Gil LJ
PLoS One; 2020; 15(12):e0243158. PubMed ID: 33259546
[TBL] [Abstract][Full Text] [Related]
38. Interval post-colonoscopy colorectal cancer following a negative colonoscopy in a fecal immunochemical test-based screening program.
van de Schootbrugge-Vandermeer HJ; Kooyker AI; Wisse PHA; Nagtegaal ID; Geuzinge HA; Toes-Zoutendijk E; de Jonge L; Breekveldt ECH; van Vuuren AJ; van Kemenade FJ; Ramakers CRB; Dekker E; Lansdorp-Vogelaar I; Spaander MCW; van Leerdam ME
Endoscopy; 2023 Dec; 55(12):1061-1069. PubMed ID: 37793423
[TBL] [Abstract][Full Text] [Related]
39. Adenoma Detection Rate in Asymptomatic Patients with Positive Fecal Immunochemical Tests.
Kligman E; Li W; Eckert GJ; Kahi C
Dig Dis Sci; 2018 May; 63(5):1167-1172. PubMed ID: 29468377
[TBL] [Abstract][Full Text] [Related]
40. Impact of colorectal cancer screening participation in remote northern Canada: A retrospective cohort study.
Smith HA; Scarffe AD; Brunet N; Champion C; Kandola K; Tessier A; Boushey R; Kuziemsky C
World J Gastroenterol; 2020 Dec; 26(48):7652-7663. PubMed ID: 33505142
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
